Absci (ABSI) Cash & Equivalents (2020 - 2026)
Absci (ABSI) posted Cash & Equivalents of $107.87 million for Q2 2026, up 183.7% from $38.02 million a year earlier.
Powered by 
Analysis
Absci (ABSI) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Absci's Cash & Equivalents came in at $20.03 million, down 51.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- In prior years, Absci's Cash & Equivalents was $41.21 million in FY2024 (-43.0%), $72.36 million in FY2023 (+20.7%), $59.96 million in FY2022 (-76.3%) and $252.57 million in FY2021 (+261.5%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q2 2022.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 18.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2024, with growth of 415.7%; the weakest was Q1 2023, with a decline of 95.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $8.63 million (Q1 2026), $20.03 million (Q4 2025) and $9.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,244.63 Bn | 1,218.25 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.17 Bn | 595.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 516.80 Bn | 484.81 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 363.56 Bn | 326.51 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.26 Bn | 288.50 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 292.48 Bn | 266.38 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.31 Bn | 201.96 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 209.33 Bn | 184.44 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.10 Bn | 114.45 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Absci | 1.72 Bn | 1.10 Bn | - | 107.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.87 Mn |
| Mar 31, 2026 | 8.63 Mn |
| Dec 31, 2025 | 20.03 Mn |
| Sep 30, 2025 | 9.48 Mn |
| Jun 30, 2025 | 38.02 Mn |
| Mar 31, 2025 | 47.00 Mn |
| Dec 31, 2024 | 41.21 Mn |
| Sep 30, 2024 | 38.20 Mn |
| Jun 30, 2024 | 42.94 Mn |
| Mar 31, 2024 | 58.83 Mn |
| Dec 31, 2023 | 72.36 Mn |
| Sep 30, 2023 | 69.73 Mn |
| Jun 30, 2023 | 61.05 Mn |
| Mar 31, 2023 | 11.41 Mn |
| Dec 31, 2022 | 59.96 Mn |
| Sep 30, 2022 | 107.32 Mn |
| Jun 30, 2022 | 206.02 Mn |
| Mar 31, 2022 | 226.00 Mn |
| Dec 31, 2021 | 252.57 Mn |
| Sep 30, 2021 | 279.26 Mn |
API Access
Absci Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();